Paper Details

  1. Home
  2. Paper Details

Once-daily ciclesonide via metered-dose inhaler: Similar efficacy and safety with or without a spacer.

Author: BeckEkkehard, EngelstätterRenate, GerberClaudia, SzlávikM

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Ciclesonide administered via metered-dose inhaler (MDI) alone or with a spacer showed similar efficacy and tolerability in patients with persistent asthma.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Inhaled corticosteroids (ICS) are recommended as first-line treatment for adults and children with persistent asthma. The Global Initiative for Asthma recommends that patients taking medium- or high-dose ICS delivered by metered-dose inhalers (MDIs) should use a spacer device. METHODS: ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.rmed.2009.06.004

データ提供：米国国立医学図書館（NLM）

Ciclesonide: A Consistent Oasis in the Desert of Asthma Management

The desert of asthma management can be a challenging landscape for individuals seeking effective and well-tolerated treatments. This research investigates the efficacy and safety of ciclesonide, an inhaled corticosteroid, delivered via metered-dose inhaler (MDI) with and without a spacer. The authors conducted a randomized, open-label, 12-week, non-inferiority study, comparing the effects of ciclesonide 160 microg once daily delivered via MDI alone or with a spacer. The results showed that ciclesonide demonstrated similar efficacy and tolerability regardless of whether it was delivered with or without a spacer, offering flexibility in treatment approaches.

Ciclesonide: A Consistent Oasis in the Desert of Asthma

The study findings suggest that ciclesonide delivered via MDI, with or without a spacer, provides effective and well-tolerated treatment for persistent asthma. This discovery, like a refreshing oasis in the desert, offers a consistent and reliable option for individuals seeking asthma management.

Navigating the Desert of Asthma: Ciclesonide Offers a Consistent Path

Ciclesonide, like a well-charted path through the desert, provides a consistent and reliable option for managing asthma. The study's findings highlight the flexibility of ciclesonide delivery, allowing for personalized treatment approaches to meet individual needs.

Dr.Camel's Conclusion

This research explores the efficacy and safety of ciclesonide, an inhaled corticosteroid, for managing persistent asthma. The findings demonstrate the effectiveness and tolerability of ciclesonide delivered via MDI, with or without a spacer. Ciclesonide provides a consistent and reliable option for managing asthma, offering a much-needed oasis in the desert of this chronic condition.

Date :
  1. Date Completed 2010-08-30
  2. Date Revised 2013-05-30
Further Info :

Pubmed ID

19596188

DOI: Digital Object Identifier

10.1016/j.rmed.2009.06.004

Related Literature

Article Analysis
・Effects of ciclesonide oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.